Candel Therapeutics Competitors and Similar CompaniesClear all
Candel Therapeutics's competitors and similar companies include Oncopeptides.
 Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ||
Founding Date | Founding Date 1999 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Needham, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US |
Employees | Employees 50 | Employees 80 |
Valuation ($) | Valuation ($) 176.8 m | Valuation ($) 42.4 m |
Financial | ||
Net income | Net income ($38.2m) (FY, 2025) | Net income (kr249.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company